SearcharxivSearch

arXiv subjects

Julia Adler-Milstein

Publications and source records attributed to Julia Adler-Milstein.

2 recordsLinked to original sources

Patient-Centered, Graph-Augmented Artificial Intelligence-Enabled Passive Surveillance for Early Stroke Risk Detection in High-Risk Individuals

Stroke affected millions annually, yet poor symptom recognition often delayed care-seeking. To address risk recognition gap, we developed a passive surveillance system for early stroke risk detection using patient-reported symptoms among individuals with diabetes. Constructing a symptom taxonomy grounded in patients own language and a dual machine learning pipeline (heterogeneous GNN and EN/LASSO), we identified symptom patterns associated with subsequent stroke. We translated findings into a hybrid risk screening system integrating symptom relevance and temporal proximity, evaluated across 3-90 day windows through EHR-based simulations. Under conservative thresholds, intentionally designed to minimize false alerts, the screening system achieved high specificity (1.00) and prevalence-adjusted positive predictive value (1.00), with good sensitivity (0.72), an expected trade-off prioritizing precision, that was highest in 90-day window. Patient-reported language alone supported high-precision, low-burden early stroke risk detection, that could offer a valuable time window for clinical evaluation and intervention for high-risk individuals.

cs.LG

Patient Safety Risks from AI Scribes: Signals from End-User Feedback

AI scribes are transforming clinical documentation at scale. However, their real-world performance remains understudied, especially regarding their impacts on patient safety. To this end, we initiate a mixed-methods study of patient safety issues raised in feedback submitted by AI scribe users (healthcare providers) in a large U.S. hospital system. Both quantitative and qualitative analysis suggest that AI scribes may induce various patient safety risks due to errors in transcription, most significantly regarding medication and treatment; however, further study is needed to contextualize the absolute degree of risk.

cs.CY